Next-Generation Sequencing (NGS) is increasingly being used for HLA typing. Several NSG-based protocols have recently being developed by various companies by building their respective NGS platforms. The report ?Global Transplant Diagnostic Market (HLA Typing - Molecular Assays and Non-Molecular Assays; Product Type - Reagents & Consumables, Instruments & Software & Services) Market Outlook 2024? provides information on the current scenario, market outlook of the global transplant diagnostic. The market is segmented along types of HLA Typing and Product type. Detailed analysis of these segments are provided in the report. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. Market outlook for overall market as well as for various segments for aforementioned regions has been provided for the period 2018-24.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global transplant diagnostic market. The report has been segmented as following:-
Market Segments
? HLA Typing - Molecular Assays & Non-Molecular Assays
? Product Type - Reagents & Consumables, Instruments & Software & Services
Geographical Coverage
? North America - The US
? Europe - Italy
? Asia Pacific
Companies Coverage
? Thermo Fisher Scientific Inc.
? F.Hoffman-La Roche Ltd.,
? Abbott Laboratories Inc.
? Qiagen N.V.
? Immucor Inc.
?

Transplantation refers to the process of replacing damaged or missing organs from donor site. In order to determine tissue compatibility between potential donor and recipient, Human leukocyte diagnostic (HLA) testing is performed. Human leukocyte antigens are basically histocompatibility complex found on cell surface that are used as markers by immune system to recognize cells which belongs to the body. HLA typing maximizes the chances of graft survival while minimizing serious immunologic transplant complications. These tests are performed using various assays- Molecular assays (Serology and Mixed Lymphocyte Culture (MLC) and Non-molecular assays (Polymerase Chain Reaction and Next Generation Sequencing).
Global transplant diagnostic market is driven by rising demand for organ transplants, increasing geriatric population, prevalence of chronic diseases and various favorable government initiatives. However, factors such as organ shortage for transplant, limited medical reimbursement, lack of awareness and stringent regulatory norms are restraining growth of the market.
The report ?Global Transplant Diagnostic Market (HLA Typing - Molecular Assays and Non-Molecular Assays; Product Type - Reagents & Consumables, Instruments & Software & Services) Market Outlook 2024? provides information on the current scenario, market outlook of the global transplant diagnostic. The market is segmented along types of HLA Typing and Product type. Detailed analysis of these segments are provided in the report. Geographically, the market is segment along North America, Europe and Asia Pacific region. Future forecasts of transplant diagnostic market overall and across various sub-segments has been provided till 2024, for all the geographies. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global transplant diagnostic market includes Thermo Fisher Scientific Inc., F.Hoffman-La Roche Ltd., Abbott Laboratories Inc., Qiagen N.V., Immucor Inc., among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global as well as regional transplant diagnostic market.